|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2008-5-27
|
|
pubmed:abstractText |
Rush immunotherapy (RIT) can confer rapid clinical benefit on patients with allergic rhinitis or asthma. However, biomarkers representing mechanisms for the efficacy of RIT are still to be established. CD203c is a basophil activation marker known to be upregulated by cross-linking of the FcepsilonRIalpha receptor and may serve as a useful marker.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0097
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
146 Suppl 1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
47-53
|
|
pubmed:meshHeading |
pubmed-meshheading:18504407-Adolescent,
pubmed-meshheading:18504407-Adult,
pubmed-meshheading:18504407-Allergens,
pubmed-meshheading:18504407-Basophils,
pubmed-meshheading:18504407-Biological Markers,
pubmed-meshheading:18504407-Child,
pubmed-meshheading:18504407-Cryptomeria,
pubmed-meshheading:18504407-Female,
pubmed-meshheading:18504407-Humans,
pubmed-meshheading:18504407-Immunoglobulin E,
pubmed-meshheading:18504407-Immunoglobulin G,
pubmed-meshheading:18504407-Immunotherapy,
pubmed-meshheading:18504407-Male,
pubmed-meshheading:18504407-Phosphoric Diester Hydrolases,
pubmed-meshheading:18504407-Pollen,
pubmed-meshheading:18504407-Pyrophosphatases,
pubmed-meshheading:18504407-Quality of Life,
pubmed-meshheading:18504407-Questionnaires,
pubmed-meshheading:18504407-Rhinitis, Allergic, Seasonal
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis.
|
|
pubmed:affiliation |
Institute for Clinical Research, Mie National Hospital, Mie, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
